Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time? Joseph M. ObeidPaul R. KunkOsama E. Rahma Review 20 October 2017 Pages: 161 - 174
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies Kristina Buder-BakhayaKarolina BenesovaJessica C. Hassel Original Article 10 October 2017 Pages: 175 - 182
A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer Paola MurgasNicolás BustamanteAlvaro Lladser Original Article 12 October 2017 Pages: 183 - 193
Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice Jill P. SmithShangzi WangLouis M. Weiner Original Article 17 October 2017 Pages: 195 - 207
Clinicopathologic implications of CD8+/Foxp3+ ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients Ming-Xiang ZouKe-Miao GuoXiao-Ling She Original Article 20 October 2017 Pages: 209 - 224
Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia Nina RolfKinga K. SmolenGregor S. D. Reid Original Article 20 October 2017 Pages: 225 - 236
NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma Zhenjiang LiuThomas PoiretMarkus Maeurer Original Article Open access 20 October 2017 Pages: 237 - 246
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice Timothy S. FisherAndrea T. HooperChad May Original Article 24 October 2017 Pages: 247 - 259
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer Yichou WeiChao LinJiejie Xu Original Article 31 October 2017 Pages: 261 - 269
Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells Na LiJianing WangYongyu Shi Original Article 31 October 2017 Pages: 271 - 283
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients Olivier GasserKatrina J. SharplesIan F. Hermans Original Article 01 November 2017 Pages: 285 - 298
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma Qi LiuHongda ZhuLeaf Huang Original Article 01 November 2017 Pages: 299 - 310
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells Tamson MooreCourtney Regan WagnerMichael I. Nishimura Original Article 20 October 2017 Pages: 311 - 325
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells Tamson MooreCourtney Regan WagnerMichael I. Nishimura Correction 20 December 2017 Pages: 327 - 327
Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy Xiaopeng YuanMingjuan YangGeorge Coukos Correction 08 January 2018 Pages: 329 - 339